Acumen Pharmaceuticals
Earnings Surprise
Analysts estimated ABOS earnings of $-0.46 per share this quarter (Q4). ABOS's actual earnings were $-0.41 per share.
ABOS EPS surprise of 11.29%Analysts estimated ABOS earnings of $-0.62 per share this quarter (Q3). ABOS's actual earnings were $-0.44 per share.
ABOS EPS surprise of 28.54%Analysts estimated ABOS earnings of $-0.55 per share this quarter (Q2). ABOS's actual earnings were $-0.68 per share.
ABOS EPS surprise of -23.91%Analysts estimated ABOS earnings of $-0.55 per share this quarter (Q1). ABOS's actual earnings were $-0.48 per share.
ABOS EPS surprise of 12.20%Analysts estimated ABOS earnings of $-0.49 per share this quarter (Q4). ABOS's actual earnings were $-0.62 per share.
ABOS EPS surprise of -26.63%Analysts estimated ABOS earnings of $-0.37 per share this quarter (Q3). ABOS's actual earnings were $-0.50 per share.
ABOS EPS surprise of -34.30%Analysts estimated ABOS earnings of $-0.29 per share this quarter (Q2). ABOS's actual earnings were $-0.34 per share.
ABOS EPS surprise of -19.05%Analysts estimated ABOS earnings of $-0.27 per share this quarter (Q1). ABOS's actual earnings were $-0.25 per share.
ABOS EPS surprise of 5.73%Analysts estimated ABOS earnings of $-0.27 per share this quarter (Q4). ABOS's actual earnings were $-0.29 per share.
ABOS EPS surprise of 9.35%Analysts estimated ABOS earnings of $-0.27 per share this quarter (Q3). ABOS's actual earnings were $-0.24 per share.
ABOS EPS surprise of -11.54%